Nobivac Canine 1-DAPPv+L4 Vaccine

Supplied By: Merck (099336)


SKU
038883


Unit of
Measure 25 x 1 Dose


Pack
Type Box


Case
Qty 1

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023 Apr- 2023
{{purchaseHistoryItem}}


SKU 038883


Size 25 x 1 Dose

Case
Qty 1

Purchase History

Apr- 2024 {{productPurchaseHistory['038883'][0]}} Sep- 2023 {{productPurchaseHistory['038883'][0+7]}}
Mar- 2024 {{productPurchaseHistory['038883'][1]}} Aug- 2023 {{productPurchaseHistory['038883'][1+7]}}
Feb- 2024 {{productPurchaseHistory['038883'][2]}} Jul- 2023 {{productPurchaseHistory['038883'][2+7]}}
Jan- 2024 {{productPurchaseHistory['038883'][3]}} Jun- 2023 {{productPurchaseHistory['038883'][3+7]}}
Dec- 2023 {{productPurchaseHistory['038883'][4]}} May- 2023 {{productPurchaseHistory['038883'][4+7]}}
Nov- 2023 {{productPurchaseHistory['038883'][5]}} Apr- 2023 {{productPurchaseHistory['038883'][5+7]}}
Oct- 2023 {{productPurchaseHistory['038883'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

NOBIVAC® Canine 1-DAPPv+L vaccine is a combination vaccine that unites the benefits of NOBIVAC Canine 1-DAPPv and NOBIVAC Lepto in one vaccination. NOBIVAC Canine 1-DAPPv vaccine is a modified live virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, canine adenovirus type 1 (hepatitis), canine parainfluenza virus, and canine parvovirus. Data indicate the development of corneal opacity is not associated with the use of this product. NOBIVAC Lepto bacterin is recommended for the vaccination of healthy dogs as an aid in the prevention of disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, and L. grippotyphosa; the prevention of leptospiruria (shedding of Leptospira in the urine) caused by L. canicola, L. icterohaemorrhagiae, and L. grippotyphosa; and as an aid in the prevention of leptospiruria caused by L. pomona.

Features & Benefits

  • Contains CPV-2b, the most prevalent field strain of parvovirus high antigenic mass (titer)
  • Low passage parvovirus vaccine
  • Overrides maternal antibodies in young puppies
  • The only leptospirosis vaccine as an aid in the prevention of disease and mortality, and prevents urinary shedding
  • Prevented mortality caused by 4 virulent Leptospira serovars